Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

263
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
263
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

152
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
152
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

187
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
187
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
What is Monogastric Digestion?01:50

What is Monogastric Digestion?

70.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.9K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

414
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.

PloS one·2026
Same author

Dogs' Detection of Symptomatic and Asymptomatic SARS-CoV-2 by Non-Working Dogs: Feasibility and Limits Under Controlled Laboratory Conditions.

Animals : an open access journal from MDPI·2026
Same author

[Evolution of the nomenclature of steatotic liver diseases: Towards a paradigm shift].

La Revue de medecine interne·2025
Same author

Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient.

Journal of medical virology·2025
Same author

Practical management of rheumatic immune-related adverse events occurring with immune checkpoint inhibitors: A narrative review.

Joint bone spine·2025
Same author

GNS561 (ezurpimtrostat), a small basic lipophilic molecule, prevents lupus phenotype in a pristane-induced lupus mouse model.

British journal of pharmacology·2025

Related Experiment Video

Updated: Jun 14, 2025

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
05:27

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

4.2K

[SIBO, from myth to reality].

Thomas Escoda1, Frédérique Retornaz1, Anne Plauzolles2

  • 1Service de médecine interne et maladie infectieuse, hôpital européen, 6, rue Désirée-Clary, 13003 Marseille, France.

La Revue De Medecine Interne
|September 5, 2024
PubMed
Summary
This summary is machine-generated.

Digestive functional disorders are common and challenging to treat. Small intestinal bacterial overgrowth (SIBO) is increasingly recognized as a factor, with new diagnostic tests and evolving therapies.

Keywords:
Digestive functional disordersIrritable bowelPullulation bactérienne de l’intestin grêleSIBOSmall intestinal bacterial overgrowthSyndromeSyndrome de l’intestin irritableTroubles digestifs fonctionnels

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.8K
Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Model in Mice
06:40

Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Model in Mice

Published on: February 10, 2023

1.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
05:27

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions

Published on: June 30, 2021

4.2K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.8K
Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Model in Mice
06:40

Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy Model in Mice

Published on: February 10, 2023

1.4K

Area of Science:

  • Gastroenterology
  • Microbiology

Context:

  • Digestive functional disorders are frequent reasons for medical consultation.
  • Current therapeutic management is difficult due to a lack of specific treatments and incomplete understanding of pathophysiology.
  • Small intestinal bacterial overgrowth (SIBO) is increasingly recognized as a common comorbidity in diverse pathologies.

Purpose:

  • To highlight the growing recognition and diagnostic accessibility of SIBO.
  • To discuss the current empirical therapeutic approaches for SIBO.
  • To emphasize the need for robust clinical trials to identify effective treatments.

Summary:

  • SIBO, once associated mainly with post-surgical cases, is now understood to be common and linked to various conditions.
  • Advances in breath testing are improving SIBO diagnosis.
  • Current treatments, primarily antibiotics and diet, are largely empirical, underscoring the need for further research.

Impact:

  • Improved diagnostic tools are making SIBO more accessible for identification.
  • Increased research interest is expected to lead to evidence-based treatment strategies.
  • This could significantly improve patient outcomes for functional gastrointestinal disorders.